KPV, a tripeptide composed of lysine-proline-valine, is an endogenously occurring fragment derived from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH). Despite its small size, ...

Koi Peptides (Koi Research Labs LLC) has introduced Klow Peptide Stack as a research-use-only multi-peptide blend for laboratory research in 2026. The product contains GHK-Cu, BPC-157, TB-500, and KPV ...

Committee will meet in July to discuss peptides now sold in gray market despite limited evidence of safety and efficacy ...

Peptide interest is exploding online, but the FDA's actual 2026 docket is far smaller than what's actually been reported.

FDA revamps peptide panel by appointing wellness clinic physicians to advise on pharmacy compounding of seven peptides, including BPC-157 and TB-500.